|
|
|
20.12.25 - 10:24
|
Vanke Hong Kong sells just 7 units in muted Le Mont weekend launch (SCMP)
|
|
|
Vanke Hong Kong, a unit of distressed mainland developer China Vanke, sold only seven flats from the latest batch of its Le Mont project in Tai Po on Saturday, a muted result that brokers said was expected given the development has been on the market for months.
The developer released 165 flats in the latest batch, with sizes ranging from 270 to 662 sq ft.
The offering included 28 one-bedroom, 28 two-bedroom, eight three-bedroom units and eight special units, as part of a six-tower residential......
|
|
|
20.12.25 - 09:42
|
ByteDance raises pay, boosts bonuses to retain staff amid AI talent war (SCMP)
|
|
|
Beijing-based ByteDance has raised pay and sweetened incentives as the TikTok owner steps up efforts to retain and attract talent globally, as it makes progress on settling the future of its US business.
In an internal letter released to all staff on Friday and seen by the Post, the social media giant said it would lift both the upper and lower limits of compensation packages for staff across all ranks.
For its full-year 2025 performance cycle – with reviews starting on January 15, 2026 –......
|
|
|
20.12.25 - 08:54
|
Chinese AI ′tiger′ Zhipu edges towards Hong Kong listing expected to raise US$300 million (SCMP)
|
|
|
Chinese artificial intelligence firm Zhipu AI has moved a step closer to a Hong Kong initial public offering to raise US$300 million after passing a listing hearing and filing its documents with Hong Kong Exchanges and Clearing on Friday.
The Beijing-based start-up, officially named Knowledge Atlas Technology Joint Stock Company Limited and marketed overseas as Z.ai, is widely seen as one of China's “new AI tigers”.
The prospectus did not disclose a fundraising target or timetable, but brokers......
|
|
|
20.12.25 - 01:06
|
Patent cliffhanger: will China biotech throw Big Pharma a lifeline? (SCMP)
|
|
|
If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of exclusivity known in the industry as the “patent cliff” – then Big Pharma is currently watching the final grains of sand slipping through the neck of the glass.
At the bottom of the hourglass awaits an unforgiving world of generic and biosimilar competition. Between 2025 and 2030, the patent cliff is set to be one of the biggest since 2010 by revenue at risk, according to......
|
|
|
20.12.25 - 00:06
|
China′s humanoid arms race: start-ups debut robots for stores, offices and factories (SCMP)
|
|
|
China's robotics industry is turning into a humanoid arms race as start-ups – fresh from big funding rounds – are rolling out new robots in a bid to beat tech giants to real-world deployment.
Beijing-based Noetix Robotics this week unveiled Hobbs W1, a service humanoid with a lifelike female face, a black bob and dexterous hands, as a new wave of venture-backed companies pushes into increasingly humanlike designs.
Noetix billed Hobbs W1 as its most humanlike robot to date.
The humanoid pairs a......
|
|
|
19.12.25 - 15:06
|
China′s Sugon unveils new AI infrastructure to rival platforms from Nvidia and Huawei (SCMP)
|
|
|
Chinese supercomputer maker Sugon has launched an advanced artificial intelligence infrastructure for data centres that is expected to rival similar high-performance platforms from Nvidia and Huawei Technologies.
Beijing-based Sugon, listed in Shanghai as Dawning Information Industry, on Thursday unveiled its scaleX platform at an event in Kunshan, a city in eastern Jiangsu province. The company claimed that it was China's first 10,000-card AI supercluster, designed to deliver in excess of 5......
|
|
|
19.12.25 - 14:00
|
Alipay+ announces sponsorship deal with WNBA team New York Liberty amid global push (SCMP)
|
|
|
Ant International, the Singapore-based affiliate of Chinese fintech giant Ant Group, on Friday announced a partnership with the Women's National Basketball Association (WNBA) team New York Liberty.
The multi-year initiative would see the company's Alipay+ fintech platform become an “official sponsor” and “innovation partner for sustainability” of the team, to “jointly support community programmes designed to advance community empowerment, environmental sustainability and youth development”......
|
|
|
19.12.25 - 13:06
|
China eyes mastery of EUV lithography, bolstering AI chip ambitions, analysts say (SCMP)
|
|
|
China's reported development of its own extreme ultraviolet (EUV) lithography machine to make advanced semiconductors for artificial intelligence and high-performance computer systems could provide a “massive” boost to the country in its tech rivalry with the United States, according to analysts.
Scientists at a high-security Shenzhen laboratory earlier this year built “what Washington has spent years trying to prevent”: a prototype EUV lithography machine, according to a Reuters report on......
|
|
|
19.12.25 - 12:55
|
China′s video game sales reach record in 2025 amid overseas expansion, AI investment (SCMP)
|
|
|
China's video game industry revenue grew 7.7 per cent to a new high this year, as domestic titles from the likes of Tencent Holdings and NetEase continued to expand globally and bets on artificial intelligence paid off, according to data released on Friday by the country's semi-official gaming industry association.
The country's gaming market posted total sales of 350.8 billion yuan (US$49.8 billion) for the year, breaking the previous record of 325.8 billion yuan set last year. The numbers were......
|
|
|
19.12.25 - 12:18
|
China Vanke says top managers have no plans to sell shares as it fights for survival (SCMP)
|
|
|
China Vanke's senior executives have no plans to reduce their personal shareholdings, according to the distressed mainland developer, which is seeking to extend the repayment of its onshore debt to avoid a default.
The Shenzhen-listed developer on Thursday was responding to queries from investors on the exchange's interactive platform, saying it had not received any notification from the executives regarding stake sale plans. Under the exchange's rules, senior management were required to......
|
|
|
19.12.25 - 11:48
|
BeOne Medicines names R&D chief Wang Lai as co-president to lead global expansion (SCMP)
|
|
|
BeOne Medicines, a global drug company that originated as a research and development (R&D) firm in Beijing, promoted Wang Lai to the newly created role of co-president, marking a leadership expansion as the company advances its late-stage pipeline and globalisation efforts.
The 48-year-old has served as the company's global head of R&D since April 2021. Effective January, Wang would take the helm of an expanded portfolio, retaining his R&D responsibilities while also overseeing business......
|
|
|
19.12.25 - 11:18
|
Need for speed: Alibaba ramps up China instant commerce push with Cainiao and Tmall tie-up (SCMP)
|
|
|
Alibaba Group's logistics arm Cainiao and online grocery business Tmall Supermarket are teaming up to expand fulfilment infrastructure and speed up deliveries, as the Chinese e-commerce giant ramps up its efforts in China's fast-growing instant commerce battle to fend off rivals such as JD.com and Meituan.
Cainiao will launch new or expand instant commerce warehouses for Tmall Supermarket across 31 mainland Chinese cities by the end of January 2026, it said in a statement on Thursday. Alibaba......
|
|
|
19.12.25 - 09:36
|
Tech pivot: Chinese AI, chip start-ups court global investors with Hong Kong listing plans (SCMP)
|
|
|
More Chinese artificial intelligence firms and chipmakers are turning to Hong Kong for fundraising, testing the appetite of global investors following stellar onshore debuts of graphics processing unit (GPU) developers Moore Threads Technology and MetaX Integrated Circuits.
GigaDevice Semiconductor is a step closer to its Hong Kong initial public offering (IPO) after passing a listing hearing, according to bourse operator Hong Kong Exchanges and Clearing (HKEX). The company is expected to......
|
|
|
19.12.25 - 08:36
|
US launches review of Nvidia′s H200 chip sales to China: sources (SCMP)
|
|
|
US President Donald Trump's administration has launched a review that could result in the first shipments to China of Nvidia's H200 chips, five sources said, making good on his pledge to allow the controversial sales.
Trump this month said he would allow sales of Nvidia's H200 chips to China, with the US government collecting a 25 per cent fee, and that the sales would help keep US firms ahead by cutting demand for Chinese-developed chips.
The move drew fire from China hawks across the US......
|
|
|
19.12.25 - 08:12
|
Rosewood presses ahead with global expansion after sources say hotel brand is not for sale (SCMP)
|
|
|
Rosewood Hotel Group said on Friday it was pushing ahead with its global expansion, announcing new openings including its first ski resort, just days after sources said Chow Tai Fook Enterprises (CTFE), the private investment holding company of the Cheng family and the parent firm of debt-ridden New World Development (NWD), had no plans to sell the prized asset.
The privately owned hotel operator said Rosewood Courchevel Le Jardin Alpin, an alpine resort in the French Alps, opened on schedule,......
|
|
|
19.12.25 - 05:00
|
Hong Kong′s focus on AI breakthroughs entices healthcare and robotics firms (SCMP)
|
|
|
Artificial intelligence (AI) – computer systems that can copy intelligent human behaviour – is rapidly transforming our world. The growing use of smart technologies in our homes and businesses, including facial or image recognition, data analysis, language understanding, problem-solving, robots and self-driving vehicles, is helping to enhance traditional human capabilities.
Hong Kong, recognised as an international finance centre with a stable digital infrastructure and hi-tech regional business......
|
|
|
19.12.25 - 04:24
|
Lawrence Lam: architect of transformation at Prudential Hong Kong (SCMP)
|
|
|
[The content of this article has been produced by our advertising partner.]
A visionary roadmap for change
Since 2022, CEO Lawrence Lam has led Prudential Hong Kong through a purposeful, phased transformation that has strengthened customer propositions and advanced change across health, digital capability and the customer experience. His leadership has gained wide recognition, earning him the title of Corporate Executive of the Year.
Lam is known for a style that builds lasting change, embraces......
|
|
|
19.12.25 - 04:00
|
From cooking oil to jet fuel: Cathay Pacific shines the spotlight on SAF (SCMP)
|
|
|
“Do you know what this is, or what this might be – the dirty-looking one?” asks Oliver Haas, the head of sustainability – commercial and innovation at Cathay Pacific, holding up a laboratory bottle filled with dark, murky liquid. The bottle contains used cooking oil, Haas explains, which is one of the raw materials most widely used for producing sustainable aviation fuel (SAF).
“And this is SAF,” Haas says, holding up another sealed bottle filled with crystal-clear liquid. “It's jet fuel –......
|
|
|
19.12.25 - 03:30
|
Hong Kong stocks head for longest rising streak in 3 weeks on cooling US inflation data (SCMP)
|
|
|
Hong Kong stocks rose for a third day on Friday, putting the benchmark gauge on course for its longest winning streak in three weeks, after softer US inflation data bolstered the case for monetary easing.
The Hang Seng Index advanced 0.3 per cent to 25,588.85 as of 10.04am local time. The Hang Seng Tech Index dropped 0.6 per cent.
On the mainland, the CSI 300 Index climbed 0.2 per cent and the Shanghai Composite Index added 0.1 per cent.
Bottled water maker Nongfu Spring gained 3.4 per cent to......
|
|
|
19.12.25 - 01:31
|
China′s pharmaceutical sector moves into the big leagues as a global innovation powerhouse (SCMP)
|
|
|
China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose infrastructure and research and development capabilities rival global pharmaceutical behemoths, according to a global consultancy.
US-based SAI MedPartners and its unit Idea Pharma recently launched a new index with the aim of highlighting Chinese drug makers and recognising their shift from generics to “true” innovation.
The consultancy released the China Pharmaceutical......
|
|